Review
Aug 2026
Dose-response efficacy and safety of the aldosterone synthase inhibitor baxdrostat in resistant hypertension: a systematic review and network meta-analysis.
Baxdrostat 1 mg and 2 mg significantly increased overall adverse events and hyperkalemia, whereas serious adverse events were not significantly increased, and both higher doses significantly increased hyperkalemia risk.
M. Shahzaib, Hafsa Ali, Muhammad Roshaan et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations